SFI
WST icon

Susquehanna Fundamental Investments’s West Pharmaceutical WST Stock Holding History

Susquehanna Fundamental Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-942
Closed -$259K – 705
2025
Q4 		$259K Hold
942
– – 0.01% 489
2025
Q3 		$247K Hold
942
– – 0.01% 497
2025
Q2 		$206K Sell
942
-2,018
-68% -$431K 0.01% 664
2025
Q1 		$663K Sell
2,960
-40,589
-93% -$11.2M 0.01% 781
2024
Q4 		$14.3M Buy
+43,549
New +$13.7M 0.2% 121
2024
Q2 		$2.13M Sell
6,454
-11,899
-65% -$4.21M 0.05% 403
2024
Q1 		$7.26M Buy
+18,353
New +$6.79M 0.34% 77

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna Fundamental Investments's WST Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 942 shares — an estimated $259K sold.

Susquehanna Fundamental Investments first reported a position in WST in Q1 2024 and held it in 7 quarters. The position peaked at $14.3M in Q4 2024. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 942 West Pharmaceutical shares in Q1 2026, an estimated $259K.
  • Susquehanna Fundamental Investments first reported a position in West Pharmaceutical in Q1 2024 and held it in 7 quarters.
  • Susquehanna Fundamental Investments's West Pharmaceutical position peaked at $14.3M in Q4 2024.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.